Egalet Corp (NASDAQ:EGLT)

9.98
Delayed Data
As of Apr 27
 -0.28 / -2.73%
Today’s Change
3.81
Today|||52-Week Range
17.03
+75.40%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$177.7M

Company Description

Egalet Corp. is a specialty pharmaceutical company using its patented technology to produce novel therapeutics on its own and with partners. The company is developing a pipeline of tamper-resistant opioids that are nearing pivotal testing based on the proprietary technology. Its products include Egalet-001, Egalet-002 and AD Opioid. The company was founded in August 2013 and is headquartered in Malvern, PA.

Contact Information

Egalet Corp.
460 E. Swedesford Road
Wayne Pennsylvania 19087
P:(484) 875-3095
Investor Relations:

Employees

Shareholders

Individual stakeholders44.40%
Other institutional3.28%
Mutual fund holders20.56%

Top Executives

Robert Samuel RadiePresident, Chief Executive Officer & Director
Stanley J. MusialChief Financial Officer
Jeffrey M. DaynoChief Medical Officer
Wendy NieblerSVP-Clinical Development & Medical Affairs
Karsten LindhardtVice President-Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account